Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

XXenon Pharmaceuticals Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
X

Xenon Pharmaceuticals Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 30, 2026MORTIMER IANPRESIDENT & CEO30,000Common Shares—Buy
Sep 30, 2026Kelly Thomas PatrickChief Financial Officer15,000Common Shares—Buy
Sep 1, 2026Svoronos DawnDirector5,144Common Shares—Option exercise
Aug 28, 2026KENNEY CHRISTOPHER JOHNChief Medical Officer7,068Common Shares—Sell
Aug 11, 2026GANNON STEVENDirector10,000Common Shares—Sell
Jun 5, 2026Cannon GillianDirector1,190Common Shares—Sell
Jun 5, 2026PATOU GARYDirector1,322Common Shares—Sell
Jun 3, 2026Svoronos DawnDirector1,593Restricted Share Units—Grant / award
Jun 3, 2026Svoronos DawnDirector10,507Share Option (Right to Buy)—Grant / award
Jun 3, 2026Cannon GillianDirector1,593Restricted Share Units—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions